Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cenovus Energy Inc (CVE) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Cenovus Energy IncTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Cenovus Energy Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Cenovus Energy Inc trades at $31.59 (market cap $57.90B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.49 (market cap $25.27B). The key difference: Cenovus Energy Inc is far larger — about 2.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and Cenovus Energy Inc pays the higher dividend (1.97%). Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

CVERPRX
Market Cap
$57.90B$25.27B
Volume
7,863,5883,671,183
Sector
EnergyHealth
52-Week High
$33.92$63.96
52-Week Low
$15.85$35.44
Typical Hold Time
46 Days0 Days
Enterprise Value
$63.84B$32.50B
Dividend Yield
1.97%1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cenovus Energy Inc

Cenovus Energy (CVE) trades at $30.63, down 1.95% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong profitability with a 20.96% ROE and 11.48% net margin, supported by recent earnings beats. Cash flow trends indicate operational strength, though net cash flow was negative $353 million in 2025. Analyst sentiment is mixed with 40.74% buy ratings, while recent news highlights growth potential and value attributes.

Outlook: CVE offers value with a low P/E of 12.43 and solid earnings growth projections, but faces headwinds from volatile oil prices and mixed technical indicators. Risks include energy market fluctuations and debt levels, though institutional interest remains steady. The stock presents a balanced opportunity for value investors seeking energy exposure.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVE
18% Buy82% Sell
Avg holding period · 46 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Cenovus Energy Inc

Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.

Read more on CVE →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →